News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,172 Results
Type
Article (62655)
Company Profile (210)
Press Release (648307)
Section
Business (200540)
Career Advice (3026)
Deals (35354)
Drug Delivery (110)
Drug Development (82207)
Employer Resources (169)
FDA (16263)
Job Trends (15393)
News (343894)
Policy (33534)
Tag
Academia (2839)
Alliances (50067)
Alzheimer's disease (1342)
Approvals (16240)
Artificial intelligence (231)
Bankruptcy (313)
Best Places to Work (11998)
Biotechnology (151)
Breast cancer (236)
Cancer (1818)
Cardiovascular disease (142)
Career advice (2555)
CAR-T (137)
Cell therapy (398)
Clinical research (66131)
Collaboration (711)
Compensation (284)
COVID-19 (2681)
C-suite (186)
Data (1699)
Diabetes (231)
Diagnostics (6432)
Earnings (76703)
Employer resources (149)
Events (109230)
Executive appointments (618)
FDA (17238)
Funding (633)
Gene therapy (279)
GLP-1 (722)
Government (4759)
Healthcare (19560)
Infectious disease (2800)
Inflammatory bowel disease (133)
Interviews (576)
IPO (16258)
Job creations (3883)
Job search strategy (2139)
Layoffs (501)
Legal (8047)
Lung cancer (262)
Manufacturing (247)
Medical device (13260)
Medtech (13265)
Mergers & acquisitions (19538)
Metabolic disorders (606)
Neuroscience (1779)
NextGen: Class of 2025 (6921)
Non-profit (4752)
Northern California (2082)
Obesity (332)
Opinion (245)
Patents (180)
People (60811)
Phase I (20474)
Phase II (28899)
Phase III (21768)
Pipeline (778)
Postmarket research (2933)
Preclinical (8731)
Radiopharmaceuticals (259)
Rare diseases (351)
Real estate (6346)
Regulatory (22587)
Research institute (2506)
Resumes & cover letters (465)
Southern California (1827)
Startups (3526)
United States (18972)
Vaccines (664)
Weight loss (238)
Date
Today (116)
Last 7 days (800)
Last 30 days (2756)
Last 365 days (34454)
2025 (5485)
2024 (35253)
2023 (39686)
2022 (50593)
2021 (55516)
2020 (54491)
2019 (48291)
2018 (36661)
2017 (33508)
2016 (33432)
2015 (38953)
2014 (32604)
2013 (28904)
2012 (30220)
2011 (30003)
2010 (28704)
Location
Africa (1000)
Arizona (169)
Asia (41737)
Australia (7272)
California (4799)
Canada (1711)
China (421)
Colorado (227)
Connecticut (247)
Europe (98013)
Florida (727)
Georgia (175)
Illinois (503)
Indiana (273)
Maryland (768)
Massachusetts (3716)
Michigan (204)
Minnesota (320)
New Jersey (1419)
New York (1418)
North Carolina (931)
Northern California (2082)
Ohio (170)
Pennsylvania (1081)
South America (1324)
Southern California (1827)
Texas (715)
Utah (156)
Washington State (487)
711,172 Results for "london school of hygiene and tropical medicine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jaguar Health Extends Collaboration for Possible Tropical Disease Priority Review Voucher and Cholera Indication for NP-300
February 19, 2025
·
7 min read
Bio NC
Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program
Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.
June 24, 2024
·
5 min read
Business
Kaiser Permanente Bernard J. Tyson School of Medicine appoints Dr. John L. Dalrymple as new Dean and CEO
The Board of Directors of the Kaiser Permanente Bernard J. Tyson School of Medicine announced the appointment of physician, educator, and women’s health expert John L. Dalrymple, MD, as the school’s new Dean and CEO after an extensive national search.
April 16, 2024
·
4 min read
Business
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine),
March 21, 2024
·
2 min read
Business
Recursion Announces Plans to Open New Office in London
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced plans to open a new office in London’s vibrant King’s Cross neighborhood.
March 11, 2024
·
6 min read
BioCapital
Collaboration with the London School of Hygiene & Tropical Medicine investigates a single-dose HPV vaccine in Tanzania
Is a single dose of a human papillomavirus (HPV) vaccine sufficient to induce an immune response capable of preventing HPV infection and cervical cancer? That is an area of focus of the Frederick National Laboratory’s HPV Serology Laboratory, this time with a new collaboration with the London School of Hygiene & Tropical Medicine School to investigate immune responses to a single dose of the HPV vaccine in girls in Tanzania.
July 10, 2020
·
2 min read
Press Releases
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis
December 23, 2024
·
8 min read
Press Releases
Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies
October 16, 2024
·
5 min read
Drug Development
Gilead Provides Update on Phase 3 TROPiCS-04 Study
Gilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from the confirmatory Phase 3 TROPiCS-04 study in locally advanced or metastatic urothelial cancer (mUC).
May 30, 2024
·
16 min read
Press Releases
Yale School of Medicine recognized by NIH for excellence in genetics of rare diseases
September 13, 2024
·
2 min read
1 of 71,118
Next